Carmine Therapeutics Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Carmine Therapeutics's estimated annual revenue is currently $2M per year.(i)
  • Carmine Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • Carmine Therapeutics has 13 Employees.(i)
  • Carmine Therapeutics grew their employee count by -55% last year.

Carmine Therapeutics's People

NameTitleEmail/Phone
1
VP CMCReveal Email/Phone
2
Associate Director, Analytical DevelopmentReveal Email/Phone
3
PresidentReveal Email/Phone
4
Principal ScientistReveal Email/Phone
5
Senior ScientistReveal Email/Phone
6
Production SpecialistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M20%N/AN/A
#3
$5.1M336%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
$5.4M353%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is Carmine Therapeutics?

Carmine Therapeutics, headquartered in Cambridge MA, is pioneering a new class of non-viral gene therapies based on red blood cell extracellular vesicles, combined with proprietary payloads. In June 2020, Carmine inked a research alliance with Takeda Pharmaceuticals worth up to $900 million to develop non-viral gene therapies for 2 targets. Carmine has also been named one of the FierceBiotech’s Fierce 15 Biotech companies of 2020 and was also awarded the Bristol-Myers Squibb "Golden Ticket". Carmine was founded in 2019 by Esco Ventures X, Professors Harvey Lodish (Whitehead, MIT), Minh Le and Jiahai Shi. Professor Lodish, who was a founding member of several successful biotech companies that include Genzyme and Millennium Pharmaceuticals, is also Chair of the Scientific Advisory Board of Carmine. For more information, visit www.carminetherapeutics.com Media Relations Media@carminetherapeutics.com Investor Relations Investors@carminetherapeutics.com

keywords:N/A

N/A

Total Funding

13

Number of Employees

$2M

Revenue (est)

-55%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2M13-24%$1M
#2
$0.4M13-13%$3.8M
#3
$1.7M13-13%N/A
#4
$2M13-13%N/A
#5
$1.3M13-24%N/A